2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
2008 | A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features | ONCOLOGY REPORTS |
2021 | Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2009 | Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect | GENE THERAPY |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | JOURNAL OF NEURO-ONCOLOGY |
2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
2007 | Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
| CANCER |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2009 | Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck | CANCER CHEMOTHERAPY AND PHARMACOLOGY |